UPDATE 1-U.S. FDA approves Alkermes' schizophrenia drug Aristada
October 05, 2015 at 20:30 PM EDT
Oct 5 (Reuters) - Alkermes PLC said on Monday the U.S. Food and Drug Administration approved its extended-release injectable version of schizophrenia treatment Abilify.